metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more
Impact factor 2023
3.7
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2023
7.9
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2023
0.289
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2023
0.941
View more metrics
Hide
Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Biological aging accelerates hepatic fibrosis: Insights from the NHANES 2017–2020 and genome-wide association study analysis
Jiaxin Zhao, Huiying Zhou, Rui Wu, Chen Ruan, Cheng Wang, Jiawei Ding, Tao Zhang, Zheyu Fang, ... Zhenhua Hu
Full text access
Uncorrected Proof. Available online 25 October 2024
FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
Mário Reis Álvares-da-Silva, Márcia da Silva Vargas, Soheyla Mohd Souza Rabie, Gabriella Jonko, Patricia Gabriela Riedel, Larisse Longo, Marcelo Rodrigues Gonçalves, Vivian Cristine Luft, Dvora Joveleviths
Full text access
Uncorrected Proof. Available online 21 October 2024
Study on the prediction model of liver cancer based on chronic liver disease and the related molecular mechanism
Xiaojing Zhang, Xinye Chen
Full text access
Uncorrected Proof. Available online 20 September 2024
View all Ahead of print
Current Issue
Issue
Vol. 29. Issue 6.
(November - December 2024)
Editorial board
Ann Hepatol. 2024;29:101592
Full text access
Editorial
Gilberta Bensabath – Centenary of the discoverer of the high prevalence of hepatitis B and Delta in the Amazon – On the path to elimination as a public health problem!
João Renato Rebello Pinho, Michele Gomes-Gouvêa, Flair José Carrilho
Ann Hepatol. 2024;29:101575
Full text access
Opinions
Global multi-societies endorsement of the MAFLD definition
Mohamed Alboraie, Tawesak Tanwandee, Xiaoyuan Xu, Dafina Nikolova, Enrique Carrera Estupiñan, Hasmik Ghazinyan, Sameer Alawadhi, Ponsiano Ocama, ... Yasser Fouad
Ann Hepatol. 2024;29:101573
Full text access
Concise reviews
The myth of the stigma of fatty liver: What does the evidence show?
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Nahum Méndez-Sánchez
Ann Hepatol. 2024;29:101535
Full text access
View all issue
Issues in progress
View all issues in progress
Archive
View all archive
Supplements
View all supplements
Instructions for authors
Most often read
Manuel Mendizabal, Guilherme Grossi Lopes Cançado, Agustín Albillos
10.1016/j.aohep.2023.101180
Ann Hepatol. 2024;29:
This article has been read 8.319 times
View all Most Often read articles
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos